Schedule 13G ownership disclosure
RXi Pharmaceuticals Corp
Security class unavailable · CUSIP: 74979C105
Event date: 2013-03-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001575872-15-000020
- Form type
- SC 13G
- Filer
- Advanced RNA Technologies, LLC
- CIK
- CIK 1572407
- Filed
- Feb 25, 2015
- Reporting period
- Mar 01, 2013
- Description
- Schedule 13G beneficial ownership